interferon-alpha 2b ( ifn-alpha ) was administered by continuous subcutaneous ( s.c. ) infusion to 23 patients with hematologic malignancies or metastatic solid tumors : 5 patients with multiple myeloma , 3 with malignant melanoma , 2 with chronic myelogenous leukemia ( cml ) , 10 patients with renal cell cancer , and 3 patients with other solid tumors .
C0021735
interferon-alpha 2b
C0026764
multiple myeloma